Clinical Trial Update: A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly Suspension [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the pharmacokinetics, tolerability, safety and efficacy of an exenatide once-weekly suspension in type 2 diabetes patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-05-14